Efficacy, safety, and tolerability of valsartan/hydrochlorothiazide in Asian patients with essential hypertension

被引：0
|
作者：
Wen-Ter Lai
Jeong-Euy Park
Neelesh Dongre
Jackson Wang
机构：
[1] Kaohsiung Medical University Hospital,Division of Cardiology, Department of Internal Medicine
[2] Samsung Medical Center,Cardiology Division
[3] Novartis Pharma AG,Scientific Operations Department, Asia
[4] Novartis (Taiwan) Co.,Pacific, Middle East & African Countries
[5] Ltd.,Scientific Operations Department
来源：
Advances in Therapy | 2011年 / 28卷
关键词：
Asian; combination therapy; efficacy; hypertension; tolerability; valsartan/hydrochlorothiazide single pill;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：427 / 438
页数：11
相关论文
共 50 条
  • [1] Efficacy, Safety, and Tolerability of Valsartan/Hydrochlorothiazide in Asian Patients with Essential Hypertension
    Lai, Wen-Ter
    Park, Jeong-Euy
    Dongre, Neelesh
    Wang, Jackson
    ADVANCES IN THERAPY, 2011, 28 (05) : 427 - 438
  • [2] Long-term efficacy, safety, and tolerability of valsartan and hydrochlorothiazide in patients with essential hypertension
    Chrysant, SG
    Wombolt, DG
    Feliciano, N
    Zheng, HJ
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1998, 59 (11): : 762 - 772
  • [3] Efficacy and tolerability of valsartan in combination with hydrochlorothiazide in essential hypertension
    Hall, WD
    Montoro, R
    Littlejohn, T
    Jain, A
    Feliciano, N
    Zheng, HJ
    CLINICAL DRUG INVESTIGATION, 1998, 16 (03) : 203 - 210
  • [4] Efficacy and Tolerability of Valsartan in Combination with Hydrochlorothiazide in Essential Hypertension
    W. Dallas Hall
    Rafael Montoro
    Thomas Littlejohn
    Adesh Jain
    Nancy Feliciano
    Hongjie Zheng
    Clinical Drug Investigation, 1998, 16 : 203 - 210
  • [5] Efficacy and tolerability of valsartan in patients with mild to moderate essential hypertension
    Nouh, MS
    Halim, SA
    SAUDI MEDICAL JOURNAL, 2002, 23 (05) : 521 - 525
  • [6] Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: Efficacy and safety compared to hydrochlorothiazide
    Hegner, G
    Faust, G
    Freytag, F
    Meilenbrock, S
    Sullivan, J
    Bodin, F
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 52 (03) : 173 - 177
  • [7] Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared to hydrochlorothiazide
    G. Hegner
    G. Faust
    F. Freytag
    S. Meilenbrock
    J. Sullivan
    F. Bodin
    European Journal of Clinical Pharmacology, 1997, 52 : 173 - 177
  • [8] THE EFFICACY AND TOLERABILITY OF AMLODIPINE AND HYDROCHLOROTHIAZIDE IN NIGERIANS WITH ESSENTIAL-HYPERTENSION
    AJAYI, AA
    AKINTOMIDE, AO
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 1995, 87 (07) : 485 - 488
  • [9] Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension
    Calhoun, David A.
    Glazer, Robert D.
    Pettyjohn, Frank S.
    Coenen, P. D. M.
    Zhao, Yanxing
    Grosso, Amie
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (08) : 2303 - 2311
  • [10] Efficacy and safety of combination of Valsartan with Hydrochorothatizide in the management of patients with essential hypertension
    Hua, O
    Li, DB
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 111A - 112A
12345